Long-Term Survivorship of Hip Resurfacing in Patients under 30

A recent study published in International Orthopaedics (2025) reports the longest follow-up to date on the outcomes of hip resurfacing arthroplasty (HRA) in patients under the age of 30. Conducted by Girard et al. at the University of Lille, the research addresses a critical gap in orthopaedic literature, as few long-term data have been available for such a young and active patient population.

The retrospective study reviewed the clinical data, and patient recorded outcome measures (PROM’s) of 103 HRAs performed in 93 patients (77 men, 16 women) with a mean age of 27.7 years.

Key Outcomes:

-        The study reported a 98% survivorship rate free from revision at 10.8 years.

-        Report demonstrated low complication rates with no dislocations or adverse wear related failures reported

-        Patients demonstrated statistically significant improvements in hip function and activity levels following hip resurfacing arthroplasty (HRA) i.e. Harris Hip Score (HHS): improved from 41.9 preoperatively to 92.8 postoperatively.

JM Comments:

The findings of this study highlight the versatility of HRA and its value in addressing the needs of an increasingly diverse patient population. Importantly, the study concludes that HRA is a safe and effective alternative to total hip arthroplasty (THA) in young, active patients, enabling a return to sport and high-impact activities.

Reference:

Girard J, Putman S, Migaud H, Urbain A, Faure PA. Ten year follow-up of hip resurfacing in patients under thirty years old. Int Orthop. 2025 Aug;49(8):1853-1860. doi: 10.1007/s00264-025-06558-5. Epub 2025 May 16. PMID: 40377662.